1. “Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us Cohort”
by Wafa Ali Aldhaleei, Tadesse M. Abegaz and Akshaya Srikanth Bhagavathula
Pharmaceuticals 2024, 17(2), 199; https://doi.org/10.3390/ph17020199
Available online: https://www.mdpi.com/1424-8247/17/2/199
2. “Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways”
by Sarfaraz K. Niazi
Pharmaceuticals 2025, 18(8), 1115; https://doi.org/10.3390/ph18081115
Available online: https://www.mdpi.com/1424-8247/18/8/1115
3. “Antimicrobial Smart Dressings for Combating Antibiotic Resistance in Wound Care”
by Alina-Georgiana Cristea (Hohotă), Elena-Lăcrămioara Lisă, Simona Iacob (Ciobotaru), Ionut Dragostin , Claudia Simona Ștefan, Iuliu Fulga, Andra Monica Anghel (Ștefan), Maria Dragan, Ionela Daniela Morariu and Oana-Maria Dragostin
Pharmaceuticals 2025, 18(6), 825; https://doi.org/10.3390/ph18060825
Available online: https://www.mdpi.com/1424-8247/18/6/825
4. “The Therapeutic Trip of Melatonin Eye Drops: From the Ocular Surface to the Retina“
by Dario Rusciano and Cristina Russo
Pharmaceuticals 2024, 17(4), 441; https://doi.org/10.3390/ph17040441
Available online: https://www.mdpi.com/1424-8247/17/4/441
5. “GNNSeq: A Sequence-Based Graph Neural Network for Predicting Protein–Ligand Binding Affinity”
by Somanath Dandibhotla, Madhav Samudrala, Arjun Kaneriya and Sivanesan Dakshanamurthy
Pharmaceuticals 2025, 18(3), 329; https://doi.org/10.3390/ph18030329
Available online: https://www.mdpi.com/1424-8247/18/3/329
